Actinogen Medical Competitors and Similar CompaniesClear all

Actinogen Medical's competitors and similar companies include Balance Therapeutics, Antibe Therapeutics, JCR Pharmaceuticals and Seelos Therapeutics.

	Actinogen Medical Actinogen Medical is a biotech company developing treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative and metabolic diseases.	Balance Therapeutics Balance Therapeutics is a clinical-stage pharmaceutical company that provides therapies to treat debilitating neurological conditions.	Antibe Therapeutics Antibe Therapeutics is a biotechnology company that specializes in the treatment of pain and inflammation.	JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.	Seelos Therapeutics Seelos Therapeutics is a clinical-stage bio-pharmaceutical company.
Founding Date	Founding Date 2014	Founding Date 2009	Founding Date 2009	Founding Date 1975	Founding Date 2016
Type	Type Public	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Sydney, AU HQ	Locations Burlingame, US HQ	Locations Toronto, CA HQ	Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP	Locations New York, US HQ New York, US
Employees	Employees N/A	Employees 4	Employees 44	Employees 934	Employees 620% increase
Valuation ($)	Valuation ($) 52 m	Valuation ($) N/A	Valuation ($) 121.9 m	Valuation ($) 533.9 m	Valuation ($) 552 k
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $7m (FY, 2023)	Revenue (est.) ¥33.1b (FY, 2025)	Revenue (est.) $2.2m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $3.9m (FY, 2023)	Cost of goods ¥8b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $5.5m (FY, 2025)	Gross profit N/A	Gross profit $3m (FY, 2023)	Gross profit ¥25.1b (FY, 2025)	Gross profit N/A
Net income	Net income ($14.7m) (FY, 2025)	Net income N/A	Net income ($19.5m) (FY, 2023)	Net income (¥4.7b) (FY, 2025)	Net income ($37.9m) (FY, 2023)